InvestorsHub Logo
Followers 5
Posts 213
Boards Moderated 0
Alias Born 08/19/2013

Re: None

Wednesday, 01/08/2014 2:29:03 PM

Wednesday, January 08, 2014 2:29:03 PM

Post# of 146240
I think you have to give NNVC 30%of success at the lowest. Plus the added odds of low TOX and No interaction with the body. The reasons many others fail.
Am I wrong NNVC is large molecule?
And will be testing it's lead indications?

Quote:

"Using data from the past seven years, the study notes that overall success rates from Phase I to approval by the Food and Drug Administration is nearly 9%, comprising lead and secondary indications. When separated, lead indications have close to a one in seven rate of approval and secondary comes in at one in 30.

The study also shows that large molecule drugs are twice as successful in gaining approval than small molecule treatments."



Read more at: http://www.pharmatimes.com/Article/11-02-15/Drug_approval_rates_worse_than_first_thought_-_BIO_report.aspx?rl=1&rlurl=/11-07-04/FDA_must_be_made_an_independent_agency_says_biotech.aspx#ixzz2ppjfZGEB
Follow us: @PharmaTimes on Twitter
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News